Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Advanced Proteome Therapeutics CorporationUS flagOther OTC
0.00
USD
-NaN
- -
149,630.00Market Cap

Advanced Proteome Therapeutics Corporation (APTCF) Stock Splits

Learn about Advanced Proteome Therapeutics Corporation's most recent 1-for-10 basis stock split on May 08, 2019. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Advanced Proteome Therapeutics Corporation's most recent stock split

Split Date: 2019-05-08
Split Ratio: 1:10
Price Before Split: $2.00
Price After Split: $0.20

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Advanced Proteome Therapeutics Corporation's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-05-081:10Yes$2.00$0.20

About Advanced Proteome Therapeutics Corporation

Company overview and industry information

Advanced Proteome Therapeutics Corporation (APTCF) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Advanced Proteome Therapeutics Corporation Summary

Last updated: 6/3/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.